Michael Gaglia is categorized under Physical Medicine, Physician/Surgeon in Kittanning, PA and active since 2012.
Michael Gaglia was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physical Medicine, Physician/Surgeon business, which does work in the B2C market, and is classified as a Physical Medicine, Physician/Surgeon, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Michael Gaglia at the company’s single location by writing to 100 Parkview Drive # 2, Kittanning, Pennsylvania PA 16201 or by phoning (724) 548-4047. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Michael Gaglia |
| Contact Person: | Michael Gaglia |
| Address: | 100 Parkview Drive # 2, Kittanning, Pennsylvania 16201 |
| Phone Number: | (724) 548-4047 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Physical Medicine, Physician/Surgeon |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Michael Gaglia was started in 2012 to provide professional Physical Medicine, Physician/Surgeon under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Michael Gaglia for inquiries that concern Michael Gaglia by calling the company number (724) 548-4047, as your correspondence is most welcome. Additionally, the physical location of the single location of Michael Gaglia can be found at the coordinates 40.818154,-79.563584 as well as the street address 100 Parkview Drive # 2 in Kittanning, Pennsylvania 16201.
For its online presence, you may visit Michael Gaglia’s website at and engage with its social media outlets through on Twitter and on Facebook.